-transparent.png){kind=logo}
A modified XC assay for murine leukemia virus (MuLV) employing splenocytes taken directly from the animal is described. This modification can be more than 1000 times more sensitive than XC plaque assays employing tissue extracts. This technique should lend itself readily to the quantitation of infectious MuLV in defined populations of lymphoid cells.
Related Publications
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
September 1982,
Journal of clinical microbiology,
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
August 1999,
Journal of virological methods,
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
April 1977,
Virology,
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
December 1970,
Virology,
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
January 1983,
Neoplasma,
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
August 2012,
Journal of visualized experiments : JoVE,
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
June 1968,
Journal of the National Cancer Institute,
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
February 1974,
Virology,
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
October 1974,
Applied microbiology,
C J Melief, and
S K Datta, and
S Louie, and
S Johnson, and
M Melief, and
R S Schwartz
July 1976,
Virology,
